Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

  • STATUS
    Recruiting
  • End date
    Aug 4, 2021
  • participants needed
    48
  • sponsor
    Amgen
Updated on 27 January 2021
body mass index

Summary

To assess the safety and tolerability of AMG 171 as single or multiple doses in subjects with obesity

Details
Condition adiposity, Obesity
Treatment Placebo, AMG 171
Clinical Study IdentifierNCT04199351
SponsorAmgen
Last Modified on27 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 65 yrs?
Gender: Male or Female
Do you have Obesity?
Do you have any of these conditions: adiposity or Obesity?
Do you have any of these conditions: Obesity or adiposity?
Do you have any of these conditions: Obesity or adiposity?
Males and females with ages between 18 and 65 years old, inclusive
Except for obesity, otherwise healthy
Body mass index (BMI) greater than or equal to 30.0 kg/m2 and less than or equal to 40.0 kg/m2 at screening
Other Inclusion criteria may apply

Exclusion Criteria

Currently receiving treatment in another investigational device or drug study
Women of childbearing potential
History or evidence of a clinically significant disorder, condition or disease that would pose a risk to subject safety or interfere with the study evaluation, procedures or completion
Other Exclusion criteria may apply
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note